Navigation Links
Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
Date:4/29/2008

ALEXANDRIA, Va., April 29 /PRNewswire/ -- Oxford Finance Corporation, the principal lender, and Comerica Bank, today announced they have finalized a $15 million senior secured loan agreement with VisualSonics Inc. Both financial institutions are established providers of senior debt to the life science community.

VisualSonics' technology, the Vevo 770, provides scientific professionals with a simple method for efficiently viewing extremely small physiological structures in their native state and is used for imaging living tissue and blood flow with near-microscopic resolution. Vevo 770 facilitates noninvasive preclinical research in cardiac and vascular disease, cancer, stem cell research and developmental biology.

"VisualSonics has an expansive business strategy that builds on our past success," stated Tom Little, president and chief executive officer of VisualSonics. "We are encouraged that Oxford Finance has joined our stakeholders to support that strategy and provide funds for VisualSonics to expand its sales and marketing efforts, launch new products and broaden our product portfolio."

"Oxford is pleased to provide financial support for the expansion of VisualSonics' business," said J. Alden Philbrick, president and chief executive officer of Oxford Finance Corporation. "Their in vivo visualization technique is proving to be an essential part of the research efforts in a variety of major diseases."

About Oxford Finance Corporation

Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, is a specialty finance firm providing senior secured loans to public and private life science companies worldwide. For 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $900 million in loans, with lines of credit ranging from $500 thousand to $30 million. Oxford is headquartered in Al
'/>"/>

SOURCE Oxford Finance Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
2. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
3. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
4. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
5. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
6. Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
7. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
8. Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
9. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
10. Wyeth Announces Executive Change in Finance Organization
11. DRI Capital Launches Structured Finance Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... medicine, today announced that all outstanding common share purchase ... to their expiry on June 15, 2015, resulting in ... "We thank our shareholders for their continued support," ... Asterias. "This exercise of warrants represents a strong vote ...
(Date:5/26/2015)... May 26, 2015 PRC Clinical, ... the Alliance for Regenerative Medicine (ARM). The ARM ... development, investment, and commercialization of transformational treatments and ... the California-based CRO focused in Clinical Trial ... cell and regenerative research working with sponsors in ...
(Date:5/25/2015)... Phenome Networks, a software-as-a-service plant breeding ... beginning May 31st, of its next-generation Phenome One software. ... Phenome Networks’ lead in the plant breeding market, through ... breeding workflow based on years of experience with plant ... and more. The new version of Phenome One, Phenome ...
(Date:5/22/2015)... , May 22, 2015 Baylor Research Institute ... Translational Genomics Research Institute (TGen) in ... focus on accelerating early detection and treatments for patients with ... both institutions will lead to new clinical trials and access ... bridging the gap from bench to bedside across Baylor ...
Breaking Biology Technology:Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 2Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 3PRC Clinical Joins 200+ Member Organizations in The Alliance for Regenerative Medicine (ARM) 2PRC Clinical Joins 200+ Member Organizations in The Alliance for Regenerative Medicine (ARM) 3Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4
... Mass. and TORONTO, April 4, 2011 ... GNBT) announced today the publication of a ... different immunotherapeutic peptide vaccines designed for immunotherapy ... is being developed by the Company,s wholly-owned ...
... April 4, 2011 ChromaDex Corporation (OTCBB: CDXC),an innovative ... and ingredients, today announced that Curtis A. Lockshin, ... Dr. Lockshin currently serves as ... K. Broad Biomedical Research Foundation, a Duke University ...
... Omeros Corporation (NASDAQ: OMER ), a biopharmaceutical ... on inflammation, bleeding and disorders of the central nervous ... and chief executive officer, is scheduled to present at ... New York City this week.  The presentation is scheduled ...
Cached Biology Technology:Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 2Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 3Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 4ChromaDex Appoints Curtis Lockshin, Ph.D., to its Board of Directors 2
(Date:4/21/2015)... Canada , April 21, 2015 ... and evolving government policies are boosting access control systems ... According to a recently published report by ... Opportunities, 2020 ", the access control systems market in ... nearly USD1.2 billion by 2020.The access control systems market ...
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... paper published today in the journal Science, scientists from ... University Hospital in Reykjavik and Uppsala University in Sweden ... (SNPs) in the sequence of the human genome that ... major subtype of glaucoma. The SNPs are located in ...
... -- Many people with long-standing high blood pressure develop ... and colleagues at Washington University School of Medicine in ... out what could explain that difference. , Their latest ... may underlie heart failure in some hypertensive patients. The ...
... if not deadly. While the desire for these substances can ... important role. The etiology of these desires is multifactorial and ... twin studies have shown that the use of these substances ... that ones sex can influence the genetic factors for alcohol ...
Cached Biology News:deCODE discovers cause of major subtype of glaucoma 2High blood pressure, low energy -- a recipe for heart failure 2Does the desire to consume alcohol and tobacco come from our genetic makeup? 2Does the desire to consume alcohol and tobacco come from our genetic makeup? 3
... to Peroxiredoxin 1 Peroxiredoxin (Prx) ... mammalian members have been known to ... apoptosis. Many isoforms (about 50 proteins), ... acid sequence homology, particularly amino-terminal region ...
... Form: buffered aqueous solution. ... from complex carbohydrates and glycoproteins. It is ... conditions where the pH must be neutral ... Unit Definition: One ...
... The Finnpipette BioControl ... innovative features as the ... universal handle fits allseven ... channel tip cone modules. ...
...
Biology Products: